Clinical trial
A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren's Syndrome
NCT02899377 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren's Syndrome
- Lead sponsor
- GlaxoSmithKline
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 18, 2016
- Completion date
- July 12, 2018
- Enrollment
- 25 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.